Clinical Trial Update: Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity [Phase 2]

View source ↗

Summary

A Phase 2 trial assesses whether adding ruxolitinib to steroids as initial therapy improves outcomes in moderate-or-higher chronic graft-versus-host disease com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Neoplasms

Drugs mentioned

• PREDNISONE (Prednisone)
• Ruxolitinib (ruxolitinib)

Snippet

Sponsor: Byung-Sik Cho | Conditions: GVHD - Graft-Versus-Host Disease, Neoplasms | Phase 2 | Status: RECRUITING